$79.16▼ 0.21 (0.26%)
Real-time prices · US MarketsQ·Score
Buy
7 / 10
Analysts see 36% upside to $108.00 consensus target.
Quality
6.7
Health
7.9
Growth
5.6
Valuation
8.1
Sentiment
6.9
Analyst Target
$108.00
▲ +36.4% from current
Price Chart
Latest News
Fundamentals
Trailing P/E
22.1×
price-to-earnings
Forward P/E
13.1×
next 12 months est.
Market Cap
$101.6B
market capitalization
Div Yield
3.58%
dividend yield
Profit Margin
13.0%
net profit margin
Gross Margin
65.2%
revenue minus COGS
ROE
9.4%
return on equity
Beta
0.76
vs S&P 500
Price / Book
—
P/B ratio
52-Week Range
$79 — $106
annual min — max
EPS — Estimate vs Actual
Frequently Asked Questions
Is MDT a good stock to buy right now?
Based on our Q·Score of 7/10, Medtronic plc. is rated "Buy". Analysts see 36% upside to $108.00 consensus target. This analysis is based on fundamentals, analyst consensus, and valuation data, and should not be considered financial advice.
What is the analyst price target for MDT?
The consensus price target for MDT is $108.00, based on the recommendations of 25 Wall Street analysts. This implies 36.4% upside from the current price of $79.16.
Is MDT overvalued or undervalued?
Medtronic plc. (MDT) appears reasonably valued or undervalued relative to analyst targets and sector peers. It trades at a 13.1× forward P/E ratio. Analysts see 36% upside to their $108.00 consensus target.
When does Medtronic plc. report its next earnings?
Medtronic plc.'s next earnings report is expected on approximately June 3, 2026.
What is Medtronic plc.'s profit margin?
Medtronic plc. has a net profit margin of 13.0%, which is solid for most industries. Its gross margin stands at 65.2%, indicating a high-margin business model.
What is MDT's dividend yield?
Medtronic plc. currently offers a dividend yield of 3.58%, which provides a solid income stream for dividend-focused investors. Dividend yields can change based on price movements and company payout decisions.
Is Medtronic plc.'s revenue growing?
Medtronic plc. is reporting modest revenue growth of 8.7%. However, earnings declined 11.8%, which warrants monitoring.
How much debt does Medtronic plc. have?
Medtronic plc. has a debt-to-equity ratio of 0.57×, reflecting a moderate debt level, which is manageable for most profitable companies. Its current ratio is 2.54×, indicating comfortable short-term liquidity.